Learn more

INST BIOENGINEERING AMMS

Overview
  • Total Patents
    143
  • GoodIP Patent Rank
    68,269
  • Filing trend
    ⇩ 100.0%
About

INST BIOENGINEERING AMMS has a total of 143 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are CHIMERA BIOENGINEERING INC, CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS and SHENZHEN IN VIVO BIOMEDICINE TECH LIMITED COMPANY.

Patent filings in countries

World map showing INST BIOENGINEERING AMMSs patent filings in countries
# Country Total Patents
#1 China 143

Patent filings per year

Chart showing INST BIOENGINEERING AMMSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chen Wei 17
#2 Chen Huipeng 13
#3 Cheng Cao 12
#4 Fu Ling 12
#5 Yanwen Jin 11
#6 Liu Gang 10
#7 Xu Junjie 10
#8 Wu Jun 9
#9 Hou Lihua 8
#10 Ling Yan 7

Latest patents

Publication Filing date Title
CN107190013A A kind of zika virus disease vaccine using people Ad5 replication-defective adenovirals as carrier
CN107034225A Prepare the method that Ebola virus glycoproteins merge mutant with stromatin
CN107033242A A kind of monoclonal antibody of anti-Ebola virus envelope glycoprotein in people source and application
CN107022007A Antigen fragment, truncate and application based on Marburg virus envelope protein
CN108203458A A kind of small peptide and its application
CN107267431A Brucella 104M vaccine strains knock out recombinant bacterium and the application of VirB2 genes
CN107267432A Brucella 104M vaccine strains knock out recombinant bacterium and the application of Per genes
CN107267430A Brucella 104M vaccine strains knock out recombinant bacterium and the application of Omp25 genes
CN107153117A A kind of predictive molecule for being used to judge targeting mab treatment tumor efficiency
CN105237640A Anthrax toxin receptor CMG2 and human serum albumin fused protein
CN104940901A ERRa and application of inhibitor of ERRa to interferon generation promotion and virus infection inhibition
CN105138715A Microbial aerosol atmospheric diffusion hazard assessment method
CN104592385A Fully humanized antibody for anti-bacillus anthracis PA antigen
CN104292331A Humanized anti-human interferon (IFN) alpha antibody and application thereof
CN104098693A Monoclonal antibody resistant to SasA (staphylococcus aureus surface protein A) antigen and application of monoclonal antibody
CN105233302A Method for preparing influenza hemagglutinin glycoprotein polymer nanoparticles
CN105085652A Platelet-derived growth factor-B mutant and preparation method and application thereof
CN105012322A Application of sunset yellow in resisting Bacillus anthraci
CN103936856A Antibody L4H7 with CD20-resistant antigen and application thereof
CN103897059A Antibody L5H7 of anit-CD20 antigen and application of antibody L5H7